Neurol. praxi. 2015;16(1):14-19

Clinical aspects of spasticity

prof. MUDr. Robert Jech, Ph.D.
Neurologická klinika a Centrum klinických neurověd, Univerzita Karlova v Praze, 1. LF a VFN v Praze

Paresis is one of the three main clinical symptoms of the upper motor neuron lesion. Other symptoms, which could worsen central palsy, are muscle shortening and increased muscle activity. Besides motor inactivity, muscle shortening is caused by the atrophy of the muscle, tendon and surrounding soft tissues and is accompanied by decreased contractility, elasticity and loss of muscle volume, all of which leads to a fixed contracture in later stages. Increased muscle activity emerges a couple of weeks or months after the central lesion and is responsible for further deterioration of the paresis. It manifests with spasticity – a sudden increase in muscle tone during a fast muscle stretch; spastic dystonia – spontaneous involuntary muscle contraction of paretic limbs under resting condition with no apparent provoking factor; spastic co-contractions – involuntary contraction of antagonist muscle during volitional contraction of the agonists in the same segment; and spastic synkinesias – aberrant motor activity in the distant segments accompanying the active movement of the paretic limb. The spastic dystonia and co-contractions are notably the most disabling signs of increased muscular activity. They belong to critical limiting factors of neurorehabilitation as they contribute to further muscle shortening. Treatment of spastic paresis is successful if simultaneously focused on the three domains of spastic paresis – stretching the muscle (for prevention of shortening), strengthening the agonists (for improvement of paresis) and weakening the antagonists (for reduction of increased muscle activity).

Keywords: spasticity, palsy, spastic dystonia, spastic co-contraction, spastic synkinesia, muscle atrophy, muscle shortening

Published: January 26, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Jech R. Clinical aspects of spasticity. Neurol. praxi. 2015;16(1):14-19.
Download citation

References

  1. Booth FW. Effect of limb immobilization on skeletal muscle. J Appl Physiol Respir Environ Exerc Physiol 1982; 52(5): 1113-1118. Go to original source... Go to PubMed...
  2. Crone C, Johnsen LL, Biering-Sorensen F, Nielsen JB. Appearance of reciprocal facilitation of ankle extensors from ankle flexors in patients with stroke or spinal cord injury. Brain 2003; 126: 495-507. Go to original source... Go to PubMed...
  3. Denny-Brown D. The cerebral control of movement. Liverpool: University Press; 1966.
  4. Dietz V, Sinkjaer T. Spastic movement disorder: impaired reflex function and altered muscle mechanics. Lancet Neurol 2007; 6(8): 725-733. Go to original source... Go to PubMed...
  5. Gracies JM. Pathophysiology of spastic paresis. I: Paresis and soft tissue changes. Muscle Nerve 2005; 31(5): 535-551. Go to original source... Go to PubMed...
  6. Gracies JM. Pathophysiology of spastic paresis. II: Emergence of muscle overactivity. Muscle Nerve 2005; 31(5): 552-571. Go to original source... Go to PubMed...
  7. Gracies JM, Bayle N, Vinti M, Alkandari S, Vu P, Loche CM, Colas C. Five-step clinical assessment in spastic paresis. Eur J Phys Rehabil Med 2010; 46(3): 411-421. Go to PubMed...
  8. Lance JW. Spasticity: disordered motor control. In: Feldman RG, Young RR, Koella WP, editors. Symposium synopsis. Chicago: Yearbook Medical; 1980: 485-494.
  9. Lundstrom E, Terent A, Borg J. Prevalence of disabling spasticity 1 year after first-ever stroke. Eur J Neurol 2008; 15(6): 533-539. Go to original source... Go to PubMed...
  10. Maynard FM, Karunas RS, Waring WP, 3rd. Epidemiology of spasticity following traumatic spinal cord injury. Arch Phys Med Rehabil 1990; 71(8): 566-569.
  11. McGuire JR. Epidemiology of Spasticity in the Adult and Child. In: Brashear A, Elovic E, editors. Spasticity - Diagnosis and Management. New York: Demos Medical Publishing, LLC.; 2011.
  12. McGuire JR. Spasticity and other signs of the upper motor neuron syndrome. In: Brashear A, Elovic E, editors. Spasticity - Diagnosis and Management. New York: Demos Medical Publishing, LLC.; 2011.
  13. Noreau L, Proulx P, Gagnon L, Drolet M, Laramee MT. Secondary impairments after spinal cord injury: a population-based study. Am J Phys Med Rehabil 2000; 79(6): 526-535. Go to original source... Go to PubMed...
  14. O'Dwyer NJ, Ada L, Neilson PD. Spasticity and muscle contracture following stroke. Brain 1996; 119 (Pt 5): 1737-1749. Go to original source... Go to PubMed...
  15. Opheim A, Danielsson A, Alt Murphy M, Persson HC, Sunnerhagen KS. Upper-limb spasticity during the first year after stroke: stroke arm longitudinal study at the university of gothenburg. Am J Phys Med Rehabil 2014; 93(10): 884-896. Go to original source... Go to PubMed...
  16. Rizzo MA, Hadjimichael OC, Preiningerova J, Vollmer TL. Prevalence and treatment of spasticity reported by multiple sclerosis patients. Mult Scler 2004; 10(5): 589-595. Go to original source... Go to PubMed...
  17. Sheean G. The pathophysiology of spasticity. Eur J Neurol 2002; 9(Suppl 1): 3-9; dicussion 53-61. Go to original source... Go to PubMed...
  18. Vinti M, Couillandre A, Hausselle J, Bayle N, Primerano A, Merlo A, Hutin E, Gracies JM. Influence of effort intensity and gastrocnemius stretch on co-contraction and torque production in the healthy and paretic ankle. Clin Neurophysiol 2013; 124(3): 528-535. Go to original source... Go to PubMed...
  19. Watkins CL, Leathley MJ, Gregson JM, Moore AP, Smith TL, Sharma AK. Prevalence of spasticity post stroke. Clin Rehabil 2002; 16(5): 515-522. Go to original source... Go to PubMed...
  20. Wichers MJ, Odding E, Stam HJ, van Nieuwenhuizen O. Clinical presentation, associated disorders and aetiological moments in Cerebral Palsy: a Dutch population-based study. Disabil Rehabil 2005; 27(10): 583-589. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.